Why Medical Marijuana Might Be a Better Investment Than Recreational Pot

Why MedReleaf Corp (TSX:LEAF) might have more upside in the long term than Aurora Cannabis Inc (TSX:ACB).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Marijuana legalization is set to take place next summer, which could be a great opportunity to lock in a position now before we see pot stocks take off even further. However, one important question that investors should consider is whether to invest in recreational pot stocks or medicinal ones.

Growth potential could vary depending on the segment

Recreational pot is all the hype with stocks like Aphria Inc (TSX:APH) and Aurora Cannabis Inc (TSX:ACB) recently seeing their share prices double. Although growth is expected to be very strong for recreational pot, there are significant challenges that could hinder this growth.

The big assumption is that existing pot users who currently buy weed from the industry’s black market will now simply purchase it from licensed suppliers instead. It’s rather ironic, to say the least, that a pot user will now buy from the very government that once imprisoned many users for possessing and using the drug.

Although the government has now turned the corner and is welcoming pot with open arms, even if the black market disappears and users buy from approved vendors, there could still be unintended consequences of widespread drug use that could be problematic.

For instance, we should consider what impact consumption will have on such things as impaired driving and addiction, and the workplace. These are all serious issues that could make the government think twice.

Investors shouldn’t forget that if the power shifts back to the conservatives in the next federal election, then all bets are off and we could see many more restrictions on marijuana, which could then undermine any potential growth in the industry.

Medical marijuana may have stronger prospects for growth

MedReleaf Corp (TSX:LEAF) focuses on marijuana for medicinal purposes, and although this doesn’t generate as much excitement as recreational pot does, it might present greater opportunities for growth.

The World Health Organization (WHO), recently released a report stating that cannabidiol (CBD), which is the key chemical found in medical marijuana, “exhibits no effects indicative of any abuse or dependence potential.” This is contrast to tetrahydrocannabinol (THC), which is found in pot used for recreational purposes to give users a high.

The WHO also went a step further, stating that “CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials.” The organization is expected to release another report in May, which will provide a more complete review of CBD.

A strong endorsement from the WHO could see medical marijuana stocks take off and lead to wider use of the product, especially from patients seeking effective pain relief without the danger of addiction.

Why this matters to investors

Medical marijuana presents significant potential for growth. Unlike recreational pot, however, it doesn’t possess the same risks that are associated with getting high. Over the long term, medical marijuana could see tremendous growth and generate significant returns for investors.

In the past year, MedReleaf has seen its revenues more than double, and unlike many recreational pot stocks, it has seen its bottom line grow as well. In 2017, the company’s profit of $11 million made up more than 27% of MedReleaf’s top line. This would prove an impressive margin by any standard.

Should you invest $1,000 in Aurora Cannabis right now?

Before you buy stock in Aurora Cannabis, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aurora Cannabis wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Investing

Medicinal research is conducted on cannabis.
Tech Stocks

Buy the Dip, Eh? 3 Canadian Stocks to Scoop Up During This Correction

Looking for value in a correction? Now could be the time to pick up these three Canadian stocks.

Read more »

dividend growth for passive income
Stocks for Beginners

The Smartest Growth Stock to Buy With $5,000 Right Now

Aritzia’s (TSX:ATZ) solid fundamentals with rising U.S. brand awareness and consistent execution across both physical and digital channels make it…

Read more »

A worker drinks out of a mug in an office.
Dividend Stocks

With Stocks Down in 2025, Should You Buy the Dip?

Should you buy the dip? In this article, I explore that question, ultimately concluding that it depends on what you…

Read more »

oil pump jack under night sky
Energy Stocks

Where Will Suncor Stock Be in 3 Years?

Suncor is performing exceptionally well, and after a record-breaking 2024, it stands well positioned to extend this momentum into 2025.

Read more »

a man relaxes with his feet on a pile of books
Dividend Stocks

Navigating the Correction: A Smart Investor’s Guide to Canadian Value Plays

Are you looking for more value from you Canadian stocks? Check out these winners on the TSX today.

Read more »

Investor wonders if it's safe to buy stocks now
Investing

Waste Connections: Buy, Sell, or Hold in 2025?

Waste Connections (TSX:WCN) stock isn't cheap, but it's still looking attractive at current prices.

Read more »

Man data analyze
Investing

Stocks on the Move That Are Still Deals Today

Magna International (TSX:MG) has been choppy but shares look cheap here.

Read more »

a sign flashes global stock data
Stock Market

My Zaniest Stock Market Predictions for 2025 

Understand the economic prediction for 2025 and the potential rebound in sectors hit by tariffs. Read more for analysis.

Read more »